Search Results 251-260 of 13422 for Relaxin-2
... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...
Part 2 — A practical approach to evaluation. Mayo Clinic physiatrist Jane Konidis, M.D., summarizes what to include in an office-based evaluation of core and ...
We will enroll 500 patients from CREST-2, all of whom receive cognitive assessments at baseline and yearly thereafter. We anticipate identifying 100 patients ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
... 2 or 3 meningioma as measured by 6-month PFS rate. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System ...
Clinical Trials · A Comparative Effectiveness Study Of Major Glycemia-lowering Medications For Treatment Of Type 2 Diabetes · More about research at Mayo Clinic.
Before Using · Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even ...
In addition to Tier 1 procedures, at each in-person follow-up visit: Tier 2 participants will also undergo MRI scanning, comprehensive cognitive assessment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.